Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Ferrara

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Translational Lung Cancer Research|April 18, 2025
Multidisciplinary management of N2 stage III non-small cell lung cancer: opportunities and challenges for radiation oncologyHongcheng Zhu, Daniel G Schep, Marta Isolano, et al.
Immunotherapy|March 29, 2021
Immune checkpoint inhibitors and chemotherapy in first-line NSCLC: a meta-analysisFausto Petrelli, Roberto Ferrara, Diego Signorelli, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four yearsGabriella Moroni, Andrea Doria, Marta Mosca, et al.
Expert Opinion on Investigational Drugs|June 13, 2015
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancerSara Pilotto, Silvia Novello, Umberto Peretti, et al.
Journal of Functional Morphology and Kinesiology|August 22, 2025
A Comparative Study of Paralympic Veterans with Either a Spinal Cord Injury or an Amputation: Implications for Personalized Nutritional AdviceIlaria Peluso, Anna Raguzzini, Elisabetta Toti, et al.
Journal of the National Cancer Institute|April 10, 2025
Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC: a reconstructed individual patient data meta-analysisAntonio Nuccio, Fabio Salomone, Alberto Servetto, et al.
JAMA Oncology|June 12, 2020
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non-Small Cell Lung CancerBaptiste Kas, Hugues Talbot, Roberto Ferrara, et al.
Journal of Clinical Medicine|June 26, 2025
Robotic Surgery Is a Safe Treatment in Very Elderly Patients with Resectable Lung CancerPierluigi Novellis, Riccardo Di Fonzo, Edoardo Bottoni, et al.
JCO Precision Oncology|February 1, 2022
Wide and Cystic Brain Metastases Reveal <i>RET</i>-Rearranged Non-Small-Cell Lung CancersFrancesco Facchinetti, Francesca Bozzetti, Letizia Gnetti, et al.
Cancers|December 8, 2020
Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung CancerBoris Duchemann, Jordi Remon, Marie Naigeon, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Translational Lung Cancer Research|April 18, 2025
Multidisciplinary management of N2 stage III non-small cell lung cancer: opportunities and challenges for radiation oncologyHongcheng Zhu, Daniel G Schep, Marta Isolano, et al.
Immunotherapy|March 29, 2021
Immune checkpoint inhibitors and chemotherapy in first-line NSCLC: a meta-analysisFausto Petrelli, Roberto Ferrara, Diego Signorelli, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four yearsGabriella Moroni, Andrea Doria, Marta Mosca, et al.
Expert Opinion on Investigational Drugs|June 13, 2015
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancerSara Pilotto, Silvia Novello, Umberto Peretti, et al.
Journal of Functional Morphology and Kinesiology|August 22, 2025
A Comparative Study of Paralympic Veterans with Either a Spinal Cord Injury or an Amputation: Implications for Personalized Nutritional AdviceIlaria Peluso, Anna Raguzzini, Elisabetta Toti, et al.
Journal of the National Cancer Institute|April 10, 2025
Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC: a reconstructed individual patient data meta-analysisAntonio Nuccio, Fabio Salomone, Alberto Servetto, et al.
JAMA Oncology|June 12, 2020
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non-Small Cell Lung CancerBaptiste Kas, Hugues Talbot, Roberto Ferrara, et al.
Journal of Clinical Medicine|June 26, 2025
Robotic Surgery Is a Safe Treatment in Very Elderly Patients with Resectable Lung CancerPierluigi Novellis, Riccardo Di Fonzo, Edoardo Bottoni, et al.
JCO Precision Oncology|February 1, 2022
Wide and Cystic Brain Metastases Reveal <i>RET</i>-Rearranged Non-Small-Cell Lung CancersFrancesco Facchinetti, Francesca Bozzetti, Letizia Gnetti, et al.
Cancers|December 8, 2020
Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung CancerBoris Duchemann, Jordi Remon, Marie Naigeon, et al.
Pageof 15